Ayala Pharmaceuticals Buy Hold or Sell Recommendation
| ADXSDelisted Stock | USD 1.38 0.34 32.69% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Ayala Pharmaceuticals is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Ayala Pharmaceuticals given historical horizon and risk tolerance towards Ayala Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Ayala Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest. Note, we conduct extensive research on individual companies such as Ayala and provide practical buy, sell, or hold advice based on investors' constraints. Ayala Pharmaceuticals. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest.
Ayala |
Execute Ayala Pharmaceuticals Buy or Sell Advice
The Ayala recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ayala Pharmaceuticals. Macroaxis does not own or have any residual interests in Ayala Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ayala Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Ayala Pharmaceuticals Trading Alerts and Improvement Suggestions
| Ayala Pharmaceuticals is not yet fully synchronised with the market data | |
| Ayala Pharmaceuticals may become a speculative penny stock | |
| Ayala Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 250 K. Net Loss for the year was (16.24 M) with profit before overhead, payroll, taxes, and interest of 3.24 M. | |
| Ayala Pharmaceuticals currently holds about 28.15 M in cash with (16.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Ayala Pharmaceuticals current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ayala analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ayala analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Recommendation Mean | 2.00 |
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Ayala Pharmaceuticals Returns Distribution Density
The distribution of Ayala Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Ayala Pharmaceuticals' future price movements. The chart of the probability distribution of Ayala Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Ayala Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ayala Pharmaceuticals returns is essential to provide solid investment advice for Ayala Pharmaceuticals.
| Mean Return | 1.81 | Value At Risk | -15.09 | Potential Upside | 30.59 | Standard Deviation | 19.28 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ayala Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ayala Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ayala . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Ayala Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Ayala Pharmaceuticals? Buying financial instruments such as Ayala OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ayala Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Sovereign ETFs Thematic Idea Now
Broad Sovereign ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Sovereign ETFs theme has 14 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Sovereign ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Ayala OTC Stock
If you are still planning to invest in Ayala Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ayala Pharmaceuticals' history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |